Search Result "iniparib"
The Antimitotic Potential of PARP Inhibitors, An Unexplored Therapeutic Alternative
Journal: Current Topics in Medicinal Chemistry
Volume: 14 Issue: 20 Year: 2014 Page: 2346-2365
Author(s): Pablo Iglesias,Jose A. Costoya
Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 6 Year: 2013 Page: 698-707
Author(s): Vijaya Galic,Robert L. Coleman,Thomas J. Herzog
Role of PARP Inhibitors in Cancer Biology and Therapy
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2012 Page: 3907-3921
Author(s): D. Davar, J. H. Beumer, L. Hamieh, H. Tawbi
Poly(ADP-Ribose) Polymerase-1 Inhibitors Drug Discovery, Design, andDevelopment as Anticancer Agents from Past to Present: A Mini-Review
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22 Issue: 12 Year: 2022 Page: 1597-1606
Author(s): Hanine AlMubayedh,Arwa AlGhamdi
Neoadjuvant Strategies for Triple Negative Breast Cancer: âState-of-the-artâ and Future Perspectives
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 1 Year: 2015 Page: 15-25
Author(s): Luisa Carbognin,Jenny Furlanetto,Cecilia Vicentini,Rolando Nortilli,Sara Pilotto,Matteo Brunelli,Francesca Pellini,Giovanni Paolo Pollini,Emilio Bria,Giampaolo Tortora
Triple-negative Breast Cancer and Poly(ADP-ribose) Polymerase Inhibitors
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 6 Year: 2012 Page: 672-677
Author(s): Youngjin Park,Ayako Moriyama,Tomoaki Kitahara,Yutaka Yoshida,Tasuku Urita,Ryoji Kato
A Review on PARP1 Inhibitors: Pharmacophore Modeling, Virtual and Biological Screening Studies to Identify Novel PARP1 Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 14 Issue: 17 Year: 2014 Page: 2020-2030
Author(s): Sardar Shamshair Singh,Jagarlapudi A.R.P. Sarma,Lakshmi Narasu,Raveendra Dayam,Shili Xu,Nouri Neamati
Targeting the BRCA1/2 Tumor Suppressors
Journal: Current Drug Targets
Volume: 15 Issue: 1 Year: 2014 Page: 17-31
Author(s): Eliot M. Rosen,Michael J. Pishvaian
The Role of PARP Inhibitors in the Treatment of Ovarian Carcinomas
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 25 Year: 2012 Page: 3770-3774
Author(s): Anna V. Tinker,Karen Gelmon
Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 1 Year: 2017 Page: 1586-1606
Author(s): Spyridon P. Basourakos,Likun Li,Ana M. Aparicio,Paul G. Corn,Jeri Kim,Timothy C. Thompson